Additional investigations utilizing in vitro models of hepatocellular carcinoma confirmed that talazoparib and MK-8776 consistently displayed cytotoxic effects against cells with compromised CYP2D6 activity. Here, CYP2D6 is linked to hepatocellular carcinoma.